Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05238038 · ClinicalTrials.gov registry record

Electrical Impedance Tomography for the Assessment of Neurological Disease

A clinical trial, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
36
Enrollment target

NCT05238038 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05238038 has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
36 participants
Enrollment target

Study Summary

Overview of study. This is an observational study that is intended to provide the first in-human data using EIT as a biomarker of muscle health in neuromuscular conditions. We will seek patients with neurological disorders (both neuromuscular and other neurological conditions) as well as healthy subjects for study. EIT measurements will be performed on appendicular muscles (in the upper and lower extremities) depending on the condition, both at rest and with contraction. EIT measurements will be repeated on an intermittent basis to assess repeatability as well disease progression or improvement over time.

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2019-06-28
Est. Completion 2023-08-23

What the Registry Record Tells You About NCT05238038

The ClinicalTrials.gov registry entry for NCT05238038 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05238038 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05238038 about?

NCT05238038 is a clinical study titled "Electrical Impedance Tomography for the Assessment of Neurological Disease". Overview of study. This is an observational study that is intended to provide the first in-human data using EIT as a biomarker of muscle health in neuromuscular conditions. We will seek patients with neurological disorders (both neuromuscular and other neurological conditions) as well as healthy sub...

What is the current status of trial NCT05238038?

This trial is currently completed. The enrollment target is 36 participants. The study started on 2019-06-28. Estimated completion is 2023-08-23.

Who is sponsoring clinical trial NCT05238038?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.